Cargando…
Abscopal effect of stereotactic radiotherapy combined with anti‐PD‐1/PD‐L1 immunotherapy: Mechanisms, clinical efficacy, and issues
Autor principal: | Zhuang, Hongqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743005/ https://www.ncbi.nlm.nih.gov/pubmed/33169937 http://dx.doi.org/10.1002/cac2.12111 |
Ejemplares similares
-
The abscopal effect and its implications for radiotherapy-immunotherapy combinations
por: Rowell, Nicholas P.
Publicado: (2023) -
Optimizing the Treatment Schedule of Radiotherapy Combined With Anti-PD-1/PD-L1 Immunotherapy in Metastatic Cancers
por: Kong, Yuehong, et al.
Publicado: (2021) -
Multiplex immunohistochemistry/immunofluorescence is superior to tumor mutational burden and PD‐L1 immunohistochemistry for predicting response to anti‐PD‐1/PD‐L1 immunotherapy
por: Hu, Weixian
Publicado: (2019) -
Precision Stereotactic Radiotherapy for Spinal Tumors: Mechanism, Efficacy, and Issues
por: Zhuang, Hongqing, et al.
Publicado: (2020) -
Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma
por: Kazandjian, Dickran, et al.
Publicado: (2021)